Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NamePerfect Medical
Stock Code01830
Company Full NameTo be extracted
Industry美容纖體
Principal Activities提供纖體美容服務,並於中國、香港及澳門經營「Perfect Shape必瘦站」品牌;提供約100種纖體療程及約80種美容療程,同時銷售纖體美容產品。
Listing Date2012-02-10
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港九龍旺角亞皆老街8號朗豪坊辨公室大樓30樓
Business Address (Hong Kong)香港九龍尖沙咀廣東道30號新港中心第一座12樓1205 – 06室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteperfectshape.com.hk
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 0.88 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2012-01-31 to 2012-02-03
Global Offering Shares250,000,000 shares
HK Public Offer Shares (Initial)25,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)225,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,000,000,000 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 220,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 1.59B
Est. Threshold HK$ 9.39B
Analysis Result HK market cap below threshold, need +489%

Valuation & Financials

Market Cap (at Offer Price)HK$ 880,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約50.3百萬港元
Period-End Cash Balance港元74.2百萬元
Listing Expenses~HK$ 31,300,000
Listing Expenses / Funds Raised~14.23%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 HKD
Income Statement
Item 2009-032010-032011-032011-07
Revenue 236,273234,857308,976134,499
Cost of sales -1,925-4,928-7,450-2,240
Other income and gains, net 21213038454
Operating profit 34,67135,71065,46339,033
Profit before tax 34,67535,73565,70139,629
Income tax expense -6,092-6,216-15,441-10,743
Profit for the year 28,58329,51950,26028,886
Profit attributable to owners 28,58329,51950,26028,886
Balance Sheet
Item 2009-032010-032011-032011-07
Cash and cash equivalents 26,28048,18374,206139,849
Trade and bills receivables 17,41211,8108,1038,980
Inventories 5111,0181,068668
Total current assets 118,194148,391188,520214,693
Total assets 149,468185,169258,872287,399
Total current liabilities 134,559145,652206,112203,378
Total liabilities 136,482147,664210,026208,994
Total equity 12,98637,50548,84678,405
Equity attributable to owners 12,98637,50548,84678,405
Cash Flow Statement
Item 2009-032010-032011-032011-07
Net cash from operating activities 19,26252,94893,54724,695
Net cash from investing activities -10,101-31,045-69,06039,328
Net cash from financing activities 97000
Net increase in cash 9,25821,90324,48764,023
Purchase of PP&E -10,872-20,564-24,390-7,567
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 0.89
First Day OpenHK$ 0.97
First Day Change1.14%
First Day Volume140696000.0
First Day Turnover133207000.0
Use of Proceeds
1、預期約128,700,000港元(約70%)將用于擴充其知名品牌 「Perfect Shape必瘦站」于中國的服務中心網絡,預期其將繼續高速增長,兼享巨大發展潛力; 2、預期約27,600,000港元(約15%)將用于截至二零一二年及二零一三年三月三十一日止年度品牌推廣及營銷活動; 3、預期約9,200,000港元(約5%)用作升級管理信息系統,并建立電子客戶關系管理平臺,讓本集團可分析客戶購買力及購買模式等客戶數據; 4、結余約18,400,000港元(約10%)用作本集團一般營運資金。

Underwriting Syndicate

Sole Sponsor (1)
CHINA EVERBRIGHT CAPITAL LIMITED CE ACE409
Overall Coordinators (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
Joint Bookrunners (2)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 ORIENTAL PATRON SECURITIES LIMITED CE ABV570
Joint Lead Managers (2)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 ORIENTAL PATRON SECURITIES LIMITED CE ABV570

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman歐陽江—
Company Secretary蘇顯龍—
No director data available.

Major Shareholders

Major Shareholders & HoldingsSure Sino Investments 38.25%(歐陽醫生全資實益擁有)、Market Event Holdings 18.75%(歐陽虹女士全資實益擁有)、Earlson Holdings 18%(歐陽慧女士全資實益擁有)
About this page

This page shows Perfect Medical (01830) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect